Budesonide
Product Images NDC 54868-3423

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 54868-3423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Budesonide (17415633 9612 4322 B1a7 9257a3ed0879 01)

Chemical structure of Budesonide showing its molecular formula C25H34O6 and molecular weight 430.5. The diagram includes a detailed skeletal formula of the compound.*

FDA Label Image

Figure 2 (17415633 9612 4322 B1a7 9257a3ed0879 02)

A line graph comparing mean change from baseline in nighttime asthma symptoms over 12 weeks among three groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily dosing of Budesonide. The graph shows symptom improvement trends with p-values indicating statistical significance for the two Budesonide doses versus placebo.*

FDA Label Image

Figure 3 (17415633 9612 4322 B1a7 9257a3ed0879 03)

A line graph showing mean change from baseline in nighttime asthma symptoms over 12 weeks for different treatment groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily. The x-axis represents time intervals from baseline to weeks 0-12, and the y-axis shows mean change from baseline in symptoms. The graph includes p-value annotations for comparisons of doses. The labeler is Physicians Total Care, Inc., and the product is Budesonide.*

FDA Label Image

Figure 4 (17415633 9612 4322 B1a7 9257a3ed0879 04)

An instructional illustration showing a person holding a blister card of tablets with one hand and pushing a tablet out of the blister with the thumb of the other hand. The figure is labeled as Figure 1.*

FDA Label Image

Figure 5 (17415633 9612 4322 B1a7 9257a3ed0879 05)

An instructional illustration showing a hand holding a small cylindrical object with an arrow indicating a twisting motion at the base of the object. The figure is labeled as Figure 2.*

FDA Label Image

Figure 6 (17415633 9612 4322 B1a7 9257a3ed0879 06)

An instructional diagram labeled Figure 3 showing a hand holding a small container while another hand inserts or removes a dropper or similar applicator from the container. The image appears to illustrate a step in using or preparing a liquid medication product.*

FDA Label Image

Figure 7 (17415633 9612 4322 B1a7 9257a3ed0879 07)

An instructional illustration labeled Figure 4 showing hands preparing a nasal spray device. One hand holds the nasal bottle upside down, while the other hand positions the spray nozzle.*

FDA Label Image

Budesonide Inhalation Suspension 0.25 mg/2 mL (3423)

Label for Budesonide inhalation suspension 0.5 mg per 2 mL, distributed by Physicians Total Care, Inc. The label includes lot number, expiration date (01/60), and a barcode. Manufactured by VIVUS Pharmaceuticals UK, Altrincham, Cheshire.*

FDA Label Image

Budesonide Inhalation Suspension 0.5 mg/2 mL (3550)

Label for Budesonide inhalation suspension, 0.25 mg per 2 mL, distributed by Physicians Total Care, Inc. The label includes lot number 0000, an expiration date of 01/60, and a barcode. The product is manufactured by Turk Pharmaceuticals UK, Runcorn, Cheshire.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.